Nanoadjuvant-triggered STING activation evokes systemic immunotherapy for repetitive implant-related infections DOI Creative Commons
Dongdong Xu, Jun Hu,

Jiawei Mei

и другие.

Bioactive Materials, Год журнала: 2024, Номер 35, С. 82 - 98

Опубликована: Янв. 24, 2024

Repetitive implant-related infections (IRIs) are devastating complications in orthopedic surgery, threatening implant survival and even the life of host. Biofilms conceal bacterial-associated antigens (BAAs) result a "cold tumor"-like immune silent microenvironment, allowing persistence IRIs. To address this challenge, an iron-based covalent organic framed nanoadjuvant doped with curcumin platinum (CFCP) was designed present study to achieve efficient treatment IRIs by inducing systemic response. Specifically, enhanced sonodynamic therapy (SDT) from CFCP combined iron ion metabolic interference increased release double-stranded DNA (dsDNA). Immunogenic dsDNA promoted dendritic cell (DC) maturation through activation stimulator interferon gene (STING) amplified stimulation neutrophils via interferon-β (IFN-β). At same time, BAA presentation aroused humoral immunity B T cells, creating long-term resistance repetitive infections. Encouragingly, served as neoadjuvant immunotherapy for sustained antibacterial protection on implants expected guide clinical IRI relapse prevention.

Язык: Английский

Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis DOI Creative Commons
Duo Wang, Guanhua Qiu, Xiaoqi Zhu

и другие.

Journal for ImmunoTherapy of Cancer, Год журнала: 2023, Номер 11(5), С. e006516 - e006516

Опубликована: Май 1, 2023

Immunosuppressive tumor microenvironment (ITM) remains an obstacle that jeopardizes clinical immunotherapy.

Язык: Английский

Процитировано

30

Multichannel Sonocatalysis Amplifiers Target IDH1‐Mutated Tumor Plasticity and Attenuate Ros Tolerance to Repress Malignant Cholangiocarcinoma DOI
Duo Wang, Xiaoqi Zhu, Xiaobo Wang

и другие.

Advanced Functional Materials, Год журнала: 2023, Номер 33(48)

Опубликована: Июль 11, 2023

Abstract Tumor adaptation‐originated tumor tolerance that compensatory mechanisms (e.g., isocitrate dehydrogenase (IDH) mutation) jointly shape is the dominant obstacle of ROS therapy. Currently, targeting a single pathway fails to fundamentally reverse complex milieu and diminish adaptation. Herein, multichannel sonocatalysis amplifier engineered via one‐pot gas diffusion method attenuate IDH1‐mutated cholangiocarcinoma plasticity therapy, wherein triptolide IR780 are co‐loaded in DSPE‐mPEG‐modified CaCO 3 nanoparticles. Triptolide can blockade Nrf2 cut off glutathione biosynthesis blockading proteomic communication, disrupt redox homeostasis potentiate IR780‐mediated sonocatalytic production. ROS‐induced mitochondria damages Ca 2+ turn aggravate accumulation, which cooperates with reprogram mitochondrial energy substance metabolism adenosine triphosphatase glutathione), hinder DNA self‐repair, impair IDH1‐mutation‐asired tolerance. Systematic experiments support these actions such amplifiers indeed /redox disarm robust IDH1‐mutation‐induced therapy against progression. Briefly, pave comprehensive avenue metabolism, target vulnerability, genomic instability‐raised treatment

Язык: Английский

Процитировано

24

Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics DOI Creative Commons
Liqiang Zhou, Yangmengfan Chen, Dong Xie

и другие.

BMEMat, Год журнала: 2024, Номер unknown

Опубликована: Март 4, 2024

Abstract Nanomedicine‐assisted sonodynamic therapy (SDT) has emerged as one of the most promising cancer therapies due to its unique advantages high penetration, non‐radiation, and excellent oxidative stress effect, but always suffered from self‐protection mechanism apoptosis resistance characteristics evolutionarily mutated cells. Regulated cell death (RCD) received increasing attention in precision treatments because significant role synergistically sensitizing reversing immunosuppressive microenvironment during SDT nanomedicine‐triggered immunogenic death. Herein, paradigmatic research RCD‐augmented tumor immunotherapeutics are typically introduced, such autophagy blockade, ferroptosis targeting, pyroptosis induction, necroptosis initiation, cuproptosis actuation, PANoptosis trigger, coordinated anti‐tumor mechanisms discussed detail. Multiple analysis focusing on currently unsolved problems future development prospects RCD‐based nano‐oncology medicine also prospected further strengthen expand scope therapeutic applications.

Язык: Английский

Процитировано

15

Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death DOI
Tengyu He, Jing Wen, Wenjian Wang

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(19)

Опубликована: Фев. 19, 2024

Abstract Triggering lysosome‐regulated immunogenic cell death (ICD, e.g., pyroptosis and necroptosis) with nanomedicines is an emerging approach for turning “immune‐cold” tumor “hot”—a key challenge faced by cancer immunotherapies. Proton sponge such as high‐molecular‐weight branched polyethylenimine (PEI) excellent at rupturing lysosomes, but its therapeutic application hindered uncontrollable toxicity due to fixed charge density poor understanding of resulted mechanism. Here, a series proton nano‐assemblies (PSNAs) self‐assembly controllable surface cytotoxicity are created. Such PSNAs constructed via low‐molecular‐weight PEI covalently bound self‐assembling peptides carrying tetraphenylethene pyridinium (PyTPE, aggregation‐induced emission‐based luminogen). Assembly assisted the peptide‐PyTPE leads enhanced positive charges PSNA. The tendency further optimized tuning hydrophilic hydrophobic components within peptide, thus resulting in PSNA highest fluorescence, density, uptake, cytotoxicity. Systematic mechanistic studies reveal that lysosome rupturing‐regulated necroptosis least two causes death. Tumor cells undergoing PSNA‐triggered ICD activate immune cells, suggesting great potential trigger anticancer immunity.

Язык: Английский

Процитировано

14

Targeting Vascular Destruction by Sonosensitizer‐Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer DOI

Yazhi He,

Taixia Wang,

Yi-Ran Song

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(30)

Опубликована: Март 22, 2024

Abstract Sonosensitizers in current sonodynamic therapy (SDT) often suffer from poor delivery efficiency, phototoxicity, and disputed safety. To overcome these issues, a sonosensitizers‐free sonocatalytic nanomissile is constructed, wherein PLGA nanoparticles as vehicles conjugate with L‐arginine (LA) aptamer XQ2d capable of adsorbing CO 2 targeting CD71‐overexpressed pancreatic cancer, respectively. The adsorbed can respond to acidic tumor microenvironment local ultrasound release bubbles enhance ultrasound‐triggered inertial cavitation, which further split H O activate dissolved produce ·OH 1 , respectively, unlocking the ROS birth. Moreover, such bubbles‐enhanced cavitation also target intratumoral vascular destruction, instigate thrombus aggregation, induce nutrition oxygen deprivation, pose hypoxia alter metabolism, thus establishing an destruction‐targeted starvation therapy. strategy different previous presence undamaged blood vessels compromises their outcomes. Especially, active allows more sonosensitizer‐free nanomissiles retain significantly magnifying against subcutaneous orthotopic cancers. Therefore, research provides promising route therapeutic platform for clinical cancer

Язык: Английский

Процитировано

14

Bioorthogonal/Ultrasound Activated Oncolytic Pyroptosis Amplifies In Situ Tumor Vaccination for Boosting Antitumor Immunity DOI
Xiaoyu Xu,

Jinling Zheng,

Na Liang

и другие.

ACS Nano, Год журнала: 2024, Номер 18(13), С. 9413 - 9430

Опубликована: Март 24, 2024

Personalized in situ tumor vaccination is a promising immunotherapeutic modality. Currently, seeking immunogenic cell death (ICD) to generate vaccines still mired by insufficient immunogenicity and an entrenched immunosuppressive microenvironment (TME). Herein, series of tetrazine-functionalized ruthenium(II) sonosensitizers have been designed screened for establishing bioorthogonal-activated vaccine via oncolytic pyroptosis induction. Based on nanodelivery-augmented bioorthogonal metabolic glycoengineering, the original selectively remolded introduce artificial target bicycle [6.1.0] nonyne (BCN) into membrane. Through specific ligation with intratumoral BCN receptors, can realize precise membrane-anchoring synchronous click-activation desired sites. Upon ultrasound (US) irradiation, activated intensively disrupt membrane dual type I/II reactive oxygen species (ROS) generation high-efficiency sonodynamic therapy (SDT). More importantly, severe damage eminently evoke maximize reverse TME, ultimately eliciting powerful durable systemic antitumor immunity. The US-triggered certified effectively inhibit growths primary distant tumors, suppress metastasis recurrence "cold" models. This bioorthogonal-driven tumor-specific induction strategy has great potential development robust vaccines.

Язык: Английский

Процитировано

13

Tumor Microenvironment‐Selective Sol–Gel Mineralization of ROS‐Responsive Stretchable and Conductive Hydrogel DOI
Akhmad Irhas Robby, Junho Yang, Eun‐Jung Jin

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(37)

Опубликована: Апрель 11, 2024

Abstract Cancer cell‐triggered sol–gel transformation of mineralized hydrogel (PAA‐MnO 2 ) is designed as a facile strategy for cancer detection by manipulating the mineralization process in presence cells. The polyacrylic acid (PAA) with calcium phosphate via carboxyl‐Ca 2+ complex initially inhibited incorporation reactive oxygen species (ROS)‐sensitive manganese oxide (MnO polymer dots (PDs). In this system, can be induced after cleaving MnO into Mn high ROS levels cells, forming PAA‐MnO and resulting naked‐eye system monitoring. Naked‐eye monitoring ROS‐responsive performed using circulator device containing circulating cells to discriminate (HeLa, PC‐3, B16F10) from normal (CHO‐K1). With PDs, not only provides physical (stretchability, viscosity) but also fluorescence‐recovery electroconductivity changes at different cancer‐cell concentrations (10 4 –10 6 mL −1 ), including distinct strain–pressure responses that wirelessly monitored smartphones. Furthermore, vivo, experiments suggest formed tumor‐bearing mice owing its excellent ROS‐scavenging activity tumor site, confirmed SOD2 gene‐expression analysis. Thus, unique approach potentially enable simple effective future point‐of‐care diagnostics.

Язык: Английский

Процитировано

12

Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy DOI
Dongfang Liu,

Mengyun Liang,

Yongyou Tao

и другие.

Biomaterials, Год журнала: 2024, Номер 309, С. 122610 - 122610

Опубликована: Май 11, 2024

Язык: Английский

Процитировано

11

Sonocatalytic oncolysis microbiota curb intrinsic microbiota lactate metabolism and blockade CD24-Siglec10 immune escape to revitalize immunological surveillance DOI

Xiulin Dong,

Hui Liu, Chao Fang

и другие.

Biomaterials, Год журнала: 2024, Номер 311, С. 122662 - 122662

Опубликована: Июнь 12, 2024

Язык: Английский

Процитировано

11

Biodegradable pyroptosis inducer with multienzyme-mimic activity kicks up reactive oxygen species storm for sensitizing immunotherapy DOI
Junrong Wang,

Luying Qiao,

Guo‐Qing Zhu

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 370, С. 438 - 452

Опубликована: Май 6, 2024

Язык: Английский

Процитировано

10